IGF1 and breast cancer: In contrast, IGF-I rescued MCF7 cells from paclitaxel-induced apoptosis, which required both PI-3K and MAPK, suggesting that the drug mechanism-specific action in IGF-I attenuated the response of breast cancer cells to doxorubicin and paclitaxel (Gooch et al, 1999).